Log in

OTCMKTS:AOBI - American Oriental Bioengineering Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: $5.00
52-Week Range N/A
Volume3 shs
Average Volume1 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of pharmaceutical and healthcare products. It operates through the manufacturing and distribution segments. Its products include prescription pharmaceutical, over-the-counter pharmaceutical, and nutraceutical products. The company was founded by Shujun Liu, Yanchun Li, and Jun Min on November 30, 1970 and is headquartered in Beijing, China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:AOBI



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive AOBI News and Ratings via Email

Sign-up to receive the latest news and ratings for AOBI and its competitors with MarketBeat's FREE daily newsletter.

American Oriental Bioengineering (OTCMKTS:AOBI) Frequently Asked Questions

What is American Oriental Bioengineering's stock symbol?

American Oriental Bioengineering trades on the OTCMKTS under the ticker symbol "AOBI."

Has American Oriental Bioengineering been receiving favorable news coverage?

Media headlines about AOBI stock have been trending somewhat positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. American Oriental Bioengineering earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for American Oriental Bioengineering.

Who are some of American Oriental Bioengineering's key competitors?

What other stocks do shareholders of American Oriental Bioengineering own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Oriental Bioengineering investors own include Nokia Oyj (NOK), Fiat Chrysler Automobiles (FCAU), Emulex (ELX), Bank of America (BAC), Vodafone Group (VOD), Intel (INTC), Himax Technologies (HIMX), Frontier Communications (FTR), Ceragon Networks (CRNT) and Ares Capital (ARCC).

Who are American Oriental Bioengineering's key executives?

American Oriental Bioengineering's management team includes the folowing people:
  • Shujun Liu, Chairman & Chief Executive Officer
  • Yan Chun Li, Chief Financial Officer, Secretary & Director

How do I buy shares of American Oriental Bioengineering?

Shares of AOBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is American Oriental Bioengineering's official website?

The official website for American Oriental Bioengineering is http://www.bioaobo.com/.

How can I contact American Oriental Bioengineering?

American Oriental Bioengineering's mailing address is NO 4018 JINTIAN ROAD ANLIAN PLAZA 12F SUITE B02, SHENZHEN F4, 518026. The company can be reached via phone at 86-451-8666-6601 or via email at [email protected]

MarketBeat Community Rating for American Oriental Bioengineering (OTCMKTS AOBI)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  86 (Vote Underperform)
Total Votes:  155
MarketBeat's community ratings are surveys of what our community members think about American Oriental Bioengineering and other stocks. Vote "Outperform" if you believe AOBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AOBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Featured Article: Stock Portfolio Tracker

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel